Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$214K Sell
960
-67
-7% -$12.2K ﹤0.01% 755
2026
Q1
$158K Buy
+1,027
New +$139K ﹤0.01% 787
2025
Q4
Sell
-892
Closed -$119K 917
2025
Q3
$119K Buy
+892
New +$122K ﹤0.01% 738
2025
Q2
Sell
-1,201
Closed -$184K 913
2025
Q1
$184K Buy
1,201
+79
+7% +$12.4K ﹤0.01% 616
2024
Q4
$168K Buy
1,122
+142
+14% +$22.3K ﹤0.01% 617
2024
Q3
$161K Sell
980
-10
-1% -$1.48K ﹤0.01% 636
2024
Q2
$137K Buy
990
+133
+16% +$18.3K ﹤0.01% 716
2024
Q1
$89.8K Buy
+857
New +$103K ﹤0.01% 727

Other funds holding DVA

Mather Group's DVA Position: Q2 2026 in Review

Mather Group reduced its DaVita (DVA) stake by 6.5% in Q2 2026, selling an estimated $12.2K and leaving 960 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #755.

Mather Group first reported a position in DVA in Q1 2024 and has held it in 8 quarters since. 631 funds tracked by Wall St. Rank hold DVA as of Q2 2026.

  • Mather Group held 960 shares of DaVita worth $214K as of Q2 2026.
  • Mather Group sold 67 DaVita shares in Q2 2026, an estimated $12.2K.
  • DaVita made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #755 holding.
  • Mather Group first reported a position in DaVita in Q1 2024 and has held it in 8 quarters since.
  • 631 funds tracked by Wall St. Rank held DaVita as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.